Literature DB >> 17090548

Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin.

Aymeric A Amelot1, Madjid Tagzirt, Guylaine Ducouret, René Lai Kuen, Bernard F Le Bonniec.   

Abstract

Platelet factor-4 (PF4/CXCL4) is an orphan chemokine released in large quantities in the vicinity of growing blood clots. Coagulation of plasma supplemented with a matching amount of PF4 results in a translucent jelly-like clot. Saturating amounts of PF4 reduce the porosity of the fibrin network 4.4-fold and decrease the values of the elastic and loss moduli by 31- and 59-fold, respectively. PF4 alters neither the cleavage of fibrinogen by thrombin nor the cross-linking of protofibrils by activated factor XIII but binds to fibrin and dramatically transforms the structure of the ensuing network. Scanning electron microscopy showed that PF4 gives rise to a previously unreported pattern of polymerization where fibrin assembles to form a sealed network. The subunits constituting PF4 form a tetrahedron having at its corners a RPRH motif that mimics (in reverse orientation) the Gly-His-Arg-Pro-amide peptides that co-crystallize with fibrin. Molecular modeling showed that PF4 could be docked to fibrin with remarkable complementarities and absence of steric clashes, allowing the assembly of irregular polymers. Consistent with this hypothesis, as little as 50 microm the QVRPRHIT peptide derived from PF4 affects the polymerization of fibrin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090548     DOI: 10.1074/jbc.M606650200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Chemokine Regulation of Angiogenesis During Wound Healing.

Authors:  Richard J Bodnar
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 2.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

3.  Osteogenic differentiation of human mesenchymal stromal cells is promoted by a leukocytes containing fibrin matrix.

Authors:  Dominik Seybold; Thomas A Schildhauer; Jan Gessmann; Gert Muhr; Manfred Köller; Bernd Roetman
Journal:  Langenbecks Arch Surg       Date:  2010-01-20       Impact factor: 3.445

Review 4.  Mechanisms of fibrin polymerization and clinical implications.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

5.  Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation.

Authors:  Christian Valladolid; Marina Martinez-Vargas; Nitin Sekhar; Fong Lam; Cameron Brown; Timothy Palzkill; Alexander Tischer; Mathew Auton; K Vinod Vijayan; Rolando E Rumbaut; Trung C Nguyen; Miguel A Cruz
Journal:  Blood Adv       Date:  2020-04-14

6.  Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.

Authors:  Manu Thomas Kalathottukaren; Libin Abraham; Piyushkumar R Kapopara; Benjamin F L Lai; Rajesh A Shenoi; Federico I Rosell; Edward M Conway; Edward L G Pryzdial; James H Morrissey; Charles A Haynes; Jayachandran N Kizhakkedathu
Journal:  Blood       Date:  2016-12-29       Impact factor: 22.113

7.  Increased thrombosis susceptibility and altered fibrin formation in STAT5-deficient mice.

Authors:  Sarah M Nordstrom; Brian A Holliday; Brandon C Sos; James W Smyth; Robert E Levy; Jonathan W Dukes; Susan T Lord; Ethan J Weiss
Journal:  Blood       Date:  2010-09-07       Impact factor: 22.113

Review 8.  Composition and Organization of Acute Ischemic Stroke Thrombus: A Wealth of Information for Future Thrombolytic Strategies.

Authors:  Jean-Philippe Desilles; Lucas Di Meglio; Francois Delvoye; Benjamin Maïer; Michel Piotin; Benoît Ho-Tin-Noé; Mikael Mazighi
Journal:  Front Neurol       Date:  2022-07-06       Impact factor: 4.086

9.  Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis.

Authors:  Lucas Di Meglio; Jean-Philippe Desilles; Véronique Ollivier; Mialitiana Solo Nomenjanahary; Sara Di Meglio; Catherine Deschildre; Stéphane Loyau; Jean-Marc Olivot; Raphaël Blanc; Michel Piotin; Marie-Christine Bouton; Jean-Baptiste Michel; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé; Mikael Mazighi
Journal:  Neurology       Date:  2019-09-20       Impact factor: 9.910

10.  The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control.

Authors:  Ektoras Hadjipanayi; Peer-Hendrik Kuhn; Philipp Moog; Anna-Theresa Bauer; Haydar Kuekrek; Lilit Mirzoyan; Anja Hummel; Katharina Kirchhoff; Burak Salgin; Sarah Isenburg; Ulf Dornseifer; Milomir Ninkovic; Hans-Günther Machens; Arndt F Schilling
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.